|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Maplight Therapeutics, Inc. (MPLT) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
0 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
6,394,117 |
6,394,117 |
6,394,117 |
| Total Buy Value |
$0 |
$108,699,989 |
$108,699,989 |
$108,699,989 |
| Total People Bought |
0 |
2 |
2 |
2 |
| Total Buy Transactions |
0 |
2 |
2 |
2 |
| Total Shares Sold |
41,438 |
41,438 |
41,438 |
41,438 |
| Total Sell Value |
$762,718 |
$762,718 |
$762,718 |
$762,718 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
5 |
5 |
5 |
5 |
| End Date |
2025-11-13 |
2025-08-12 |
2025-02-11 |
2024-02-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Malenka Robert C. |
|
– • – |
2026-02-11 |
4 |
S |
$18.00 |
$4,338 |
D/D |
(241) |
351,370 |
|
- |
|
| Garnett Timothy John |
|
– • – |
2026-02-10 |
4 |
B |
$17.89 |
$252,678 |
I/I |
14,124 |
14,124 |
0.01 |
- |
|
| Malenka Robert C. |
|
– • – |
2026-02-10 |
4 |
S |
$18.12 |
$119,991 |
D/D |
(6,622) |
351,611 |
|
- |
|
| Gillis Jonathan |
CAAO and PAO |
• – – |
2026-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
6,020 |
254,523 |
|
- |
|
| Lillie James Woodruff |
Chief Scientific Officer |
• – – |
2026-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,730 |
298,862 |
|
- |
|
| Foff Erin Pennock |
Chief Medical Officer |
• – – |
2026-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
13,360 |
403,835 |
|
- |
|
| Kreitzer Anatol |
Chief Discovery Officer |
• – – |
2026-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
6,020 |
259,928 |
|
- |
|
| Setia Vishwas |
Chief Financial Officer |
• – – |
2026-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,730 |
395,549 |
|
- |
|
| Kroeger Christopher A. |
Chief Executive Officer |
• • – |
2026-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
23,145 |
1,649,751 |
|
- |
|
| Hanson Kristopher |
General Counsel |
• – – |
2026-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,730 |
191,582 |
|
- |
|
| Malenka Robert C. |
|
– • – |
2026-02-03 |
4 |
S |
$18.00 |
$18 |
D/D |
(1) |
358,233 |
|
- |
|
| Malenka Robert C. |
|
– • – |
2026-02-02 |
4 |
S |
$18.02 |
$126,843 |
D/D |
(7,039) |
358,234 |
|
- |
|
| Malenka Robert C. |
|
– • – |
2026-01-30 |
4 |
S |
$18.11 |
$119,743 |
D/D |
(6,612) |
365,273 |
|
- |
|
| Malenka Robert C. |
|
– • – |
2026-01-29 |
4 |
S |
$18.55 |
$394,410 |
D/D |
(21,262) |
371,885 |
|
- |
|
| Malenka Robert C. |
|
– • – |
2026-01-28 |
4 |
S |
$18.61 |
$121,704 |
D/D |
(6,524) |
393,147 |
|
- |
|
| Kroeger Christopher A. |
Chief Executive Officer |
• • – |
2026-01-27 |
4 |
D |
$17.98 |
$3,670,545 |
D/D |
(204,146) |
1,626,606 |
|
- |
|
| Hanson Kristopher |
General Counsel |
• – – |
2026-01-27 |
4 |
D |
$17.98 |
$467,606 |
D/D |
(26,007) |
183,852 |
|
- |
|
| Setia Vishwas |
Chief Financial Officer |
• – – |
2026-01-27 |
4 |
D |
$17.98 |
$600,208 |
D/D |
(33,382) |
387,819 |
|
- |
|
| Kreitzer Anatol |
Chief Discovery Officer |
• – – |
2026-01-27 |
4 |
D |
$17.98 |
$756,940 |
D/D |
(42,099) |
253,908 |
|
- |
|
| Foff Erin Pennock |
Chief Medical Officer |
• – – |
2026-01-27 |
4 |
D |
$17.98 |
$802,196 |
D/D |
(44,616) |
390,475 |
|
- |
|
| Lillie James Woodruff |
Chief Scientific Officer |
• – – |
2026-01-27 |
4 |
D |
$17.98 |
$810,089 |
D/D |
(45,055) |
291,132 |
|
- |
|
| Gillis Jonathan |
CAAO and PAO |
• – – |
2026-01-27 |
4 |
D |
$17.98 |
$396,459 |
D/D |
(22,050) |
248,503 |
|
- |
|
| Novo A/s |
|
– – • |
2025-10-28 |
4 |
B |
$17.00 |
$16,199,997 |
D/D |
952,941 |
3,686,622 |
0.01 |
- |
|
| Novo A/s |
|
– – • |
2025-10-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,733,681 |
2,733,681 |
|
- |
|
| Catalyst4, Inc. |
|
– – • |
2025-10-28 |
4 |
B |
$17.00 |
$92,499,992 |
I/I |
5,441,176 |
19,697,464 |
0.01 |
- |
|
50 Records found
|
|
Page 1 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
